Back
ESC Professional Premium Access

Prognostic value of liver fibrotic markers in patients with heart failure

Session: Emerging evidence for biomarkers in heart failure
Topic: Biomarkers
Speaker: Doctor A. Tada (Rochester, US)
Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Atsushi Tada

Mayo Clinic Hospital-Rochester, Rochester (United States of America)
0 follower

4 more presentations in this session

Cardiac Troponin T level is not a predictor of mortality in patients with post-cardiotomy shock supported with venoarterial extracorporeal membrane oxygenation.

Speaker: Doctor M. Celinska-Spodar (Warsaw, PL)

Access
Abstract
Slides
Video
Thumbnail

The prognostic role of clinical features and biomarkers in patients hospitalized with cardiorenal syndromes

Speaker: Doctor P. Theofilis (Athens, GR)

Access
Abstract
Slides
Video
Thumbnail

Prognostic significance of growth differentiation factor-15 across the BMI spectrum in patients with chronic heart failure: Insights from the SUPPORT trial

Speaker: Doctor K. Teramoto (Osaka, JP)

Access
Abstract
Slides
Video
Thumbnail

Continuous measurement of percutaneous oxygen saturation during 6-minute walk test is useful for stratification of the prognostic risk in patients with heart failure

Speaker: Doctor I. Sunayama (Hyogo, JP)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Emerging evidence for biomarkers in heart failure

Speakers: Doctor A. Tada, Doctor M. Celinska-Spodar, Doctor P. Theofilis, Doctor K. Teramoto, Doctor I. Sunayama
Access
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb